辛伐他汀对急性缺血性脑卒中疗效的临床观察(2)
 |
| 第1页 |
参见附件(2571KB，2页)。
[3] 王维治主编.神经病学.第4版.北京:人民卫生出版社,2004:123-124.
[4] 陈杭军,余毅.辛伐他汀治疗颈动脉粥样硬化疗效观察.中国实用内科杂志,2005,25(7):621-622.
[5] Amin-hanjani S, Stagliano NE, Yamada M, et al.Mevastatin,anHMG-COA reductase inhibitor, reduces stroke damage and up-regulates endothelial nitric oxide synthase in mice. Stroke,2001,32:980-986.
[6] Human JA, Ubbink JB, Jerling JJ, et al. The effect of simvastatin on the plasma antioxidant concentrations in patientswith hypercholes-terolemia.Clin China Acta,1997,263(1):67-77.
[7] PantoniL, Sheikh FG, NamboodiriA MS, et al. Lovastatin and phe-nylacetate inhibit the induction of nitric oxide synthase and cyto-kines in ratprimary astrocytes, micreoglia, and macrophages. J Clin Invest,1997,100(11):2671-2679.
[8] Endres M, Laufs U, Huang Z, et al. Stroke, protection by 3-hydroxy-3-methylglutaryl(HMG)-CoA reductase inhibitorsby endothelialntric oxide synthase(cerebral blood flow/cerebral ischemia). ProcNatlAcad Sci USA,1998,95(15):8880-8885.
[9] 刘勇,杨栋梁,方云祥.他汀类药物的脑缺血保护机制的研究进展.国外医学神经病学神经外科学分册,2004,31(1):74-78.
您现在查看是摘要介绍页，详见PDF附件(2571KB，2页)。